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ABSTRACT: Treatment of readily available allene 1 with Cy2BH followed by addition 
of an aldehyde led to quaternary protected 2-amino-2-vinyl-1,3-diols in high yield and 
excellent stereochemical purity. The choice of benzoyl as N-protecting group is critical 
since the observed N- to O-Bz transfer during the process prevents later undesired 
isomerizations in the adducts and keeps all heteroatoms protected. 
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Quaternary a amino acids bearing adjacent hydroxyl functionalities are structural 
features present in numerous metabolites of biological relevance including myriocin,1 
the proteasome inhibitor lactacystin,2 and the antitumor agent (–)-altemicidin (Fig. 1).3 
Even structurally simpler a-branched serines and threonines are also important 
synthetic targets.4 Furthermore, (S)-a-vinyl serine and other a-vinyl amino acids show 
interesting biological activities as suicide inhibitors for enzymes of the amino acid 
decarboxylase class.5  
 
Figure 1. Compounds incorporating quaternary b-hydroxylated a-amino acids  
 
Sphingolipids are a family of lipids that play essential roles as structural cell membrane 
components and also in cell signalling through a complex metabolism catalyzed by 
specific enzymes.6 From a structural point of view, most mammalian sphingolipids 
share a common backbone incorporating (E)-2-amino-4-octadecen-1,3-diol 
(sphingosine). Interestingly, structural analogues of sphingosine such as quaternary 2-
vinyl compound 2 might act as selective inhibitors of these enzymes.6c 
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Figure 2. Sphingosine, compound 2 and its possible precursor  
 
We envisaged that both b-hydroxylated a-amino acids such as (S)-a-vinyl serine and 
certain analogues of sphingolipids such as compound 2, might be generated from 
protected 2-amino-2-vinyl-1,3-diols (Figure 2).7 
As part of our studies aimed at the synthesis of polyhydroxylated a-amino acids,8 we 
recently reported a new tandem reaction leading to protected tosylcarbamates 3 in high 
yields and excellent diastereoselectivities (Scheme 1).9 This simple one-pot process was 
based on the hydroboration of tosyl allene 4 with Cy2BH, followed by the addition of an 
aldehyde.  
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Scheme 1. Preparation of N-tosylcarbamates 3 and their hydrolysis and isomerization to 
5 
 
However, in practice this procedure was hampered by drawbacks related to the use of 
the N-tosyl protecting group. This enhances the electrophilic character of the carbonyl 
group in 4 favoring hydrolysis of the carbamate or its isomerization to N-
tosylcarbamates 5 in aqueous or dry basic media, respectively. Unfortunately, these 
deleterious side reactions have also been observed10 occasionally during work-up and/or 
chromatographic purification of compounds 3. On the other hand, removing the robust 
tosyl group in the final steps of a multi-step synthetic sequence could be troublesome 
limiting the synthetic utility of the methodology. 
Some of these drawbacks were encountered in our approach to the synthesis of 
vinylsphinganines such as 2, potential inhibitors of sphingosine-1-phosphate lyase. We 
envisaged that allene 1, easily obtained from 2-butyn-1,4-diol in 61% yield (Scheme 
2)11 with the easily removable benzoyl N-protecting group, might be a better choice 
since it should be bulky enough to promote high stereoselectivity in the hydroboration 
step. 
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Scheme 2. Synthesis of allene 1 from 2-butyn-1,4-diol 
 
When allene 1 was hydroborated with dicyclohexylborane in CH2Cl2 followed by 
addition of isobutyraldehyde and treatment with triethanolamine, carbamate 6a was 
isolated in 78% yield (Scheme 3). As expected, a single diastereoisomer was obtained. 
Presumably, the relative stereochemistry of 6a arises from the hydroboration of the less 
hindered face of allene 1 to afford the corresponding (Z)-2-alkenylborane that is added 
to the aldehyde through a six-membered transition state where 1,3-axial interactions are 
minimized. Surprisingly, N to O migration of the benzoyl group in carbamate 6a had 
also occurred.12 A corresponding migration was not observed when tosylated allene 4 
was subjected to similar transformations. As expected, protected carbamate 6a was 
stable under basic, non-nucleophilic conditions (DBU) and the ring isomerization 
observed in the case of tosylcarbamates 5 did not occur with the benzoyl derivative. 
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Scheme 3. Addition of allene 1 to isobutyraldehyde 
 
The reaction was repeated with a variety of aldehydes (Table 1), in order to explore its 
scope. Carbamates 6 were obtained in good yields for aliphatic (entries 1 and 2), 
aromatic (entry 3), a,b-alkenyl (entries 4 and 5) and a,b-alkynyl aldehydes (entry 6). In 
all cases N to O migration of the benzoyl group was observed. Furthermore, a single 
diastereomer13 was always obtained including in the cases of those carbamates that 
might be useful in the synthesis of SPL inhibitors (entries 2, 5 and 6).  
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Entry R Product Yield  
1 ethyl 6b 81% 
2 dodecanyl 6c 69% 
3 phenyl 6d  82% 
4 vinyl 6e 84% 
5 (E)-1-undecenyl 6f  74% 
6 1-heptynyl 6g  90% 
   
Table 1. Addition of allene 1 to aldehydes 
 
Enantiopure carbamates were obtained when the reaction was performed with chiral 
aldehydes that exhibited strong stereofacial selectivity such as those derived from (R)-
glyceraldehyde or (R)-lactaldehyde (Scheme 4). Again, only one stereoisomer of 6h and 
6i were obtained in good yield with complete migration of the benzoyl group. 
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Scheme 4. Addition of allene 1 to enantiopure aldehydes. 
 
Compound 6i was used to check the deprotection steps in the synthesis of sphingosine 
derivatives such as myriocin (Figure 1) and we confirmed that this fully orthogonally 
protected carbamate can be partially deprotected (Scheme 5). Thus, treatment of 
carbamate 6i with K2CO3 in MeOH removed the benzoyl group (86% yield) with only 
partial migration (10%) of the TBDPS group to the oxygen atom previously protected 
by the benzoyl group. Complete removal of the TBDPS group was achieved by 
treatment with TBAF and afforded carbamate 7 (78% yield). In the absence of the tosyl 
group, concomitant isomerization of the carbamate, as occurred when it was present 
(see Scheme 1), was minimized. 
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Scheme 5. Deprotection of 6i to give 7 
 
In summary, allene 1 is a useful starting material for the synthesis of protected 
quaternary 2-amino-2-vinyl-1,3-diols by hydroboration followed by aldehyde addition 
since it avoids undesired migrations and affords a fully protected carbamate with 
complete stereoselectivity from a range of aldehydes in one step.  
 
Experimental Section 
All reactions involving moisture- or air-sensitive reagents were performed in oven-dried 
glassware under N2. Chemical shifts (d) are quoted in parts per million and in 1H NMR 
are referenced to internal TMS (for CDCl3). 13C NMR are referenced to CDCl3 (d 77.0 
ppm). Column chromatography was performed on silica gel (Merck 230-400 mesh). 
HRMS analyses were recorded on a LC/MSD-TOF mass spectrometer. Chiral 
aldehydes were prepared from D-mannitol14 and (R)-methyl lactate.15 
3-Benzoyl-4-vinylideneoxazolidin-2-one (1). A solution of benzoyl isocyanate (4.20 g, 
25.6 mmol) in anhydrous CH2Cl2 (20 mL) was added to 2-butyn-1,4-diol (1.00 g, 11.6 
mmol) at 0 ºC under N2 atmosphere. The mixture was stirred for 5 hours at rt and the 
solvent was removed. A solution of Pd2(dba)3·CHCl3 (0.055 g, 0.05 mmol) in anhydrous 
THF (40 mL) and triethylamine (0.087 mL, 0.64 mmol) were added under N2 
atmosphere. The mixture was stirred for 16 h at rt and filtered through a pad of Celite. 
The solid was washed with EtOAc. The solvent was removed and the crude residue was 
purified by column chromatography (hexanes/EtOAc 4:1) to afford 0.595 g (61%) of 
allene 1: yellow solid; mp 102-103 ºC (lit.11 101.2-103 ºC); Rf (hexanes/EtOAc 2:1) = 
0.35; 1H NMR (400 MHz, CDCl3) d 7.68 (m, 2H), 7.57 (m, 1H), 7.45 (m, 2H), 5.57 (t, J 
= 4.7 Hz, 2H), 5.04 (t, J = 4.7 Hz, 2H); 13C NMR (101 MHz, CDCl3) d 193.6, 167.3, 
151.9, 132.8, 129.2, 128.1, 128.0, 103.9, 90.4, 63.9; IR (film): 1792, 1689, 1331, 1308, 
1157, 1068 cm-1; HRMS (ESI+) calculated for C12H10NO3 [M+H]+ = 216.0655, found = 
216.0651. 
General procedure for the allene hydroboration-aldehyde addition tandem process 
A solution of the allene (1.00 equiv, 1.20 mM) in anhydrous CH2Cl2 was added to a 
suspension of Cy2BH (1.20 equiv, 1.40 mM) in CH2Cl2 at 0 ºC and under nitrogen 
atmosphere. The resulting mixture was stirred for 10 min at 0 ºC and for 1 h at rt. The 
resulting solution was then cooled to – 78 ºC, and the aldehyde (1.40 equiv) was added. 
The reaction was stirred for 4 h at rt, and was then quenched by addition of 
triethanolamine (2.50 equiv). The resulting mixture was stirred for 1 h at rt. Solvent 
removal gave a crude that was purified by flash column cromatography yielding the 
following adducts: 
(RS)-2-Methyl-1-[(SR)-2-oxo-4-vinyloxazolidin-4-yl]propyl benzoate (6a), 0.221 g 
(78%) from 0.210 g (0.98 mmol) of allene 1 as a colorless oil; Rf (hexanes/EtOAc 7:3) = 
0.20; 1H NMR (400 MHz, CDCl3) d 8.04 (d, J = 7.6 Hz, 2H), 7.61 (t, J = 7.6 Hz, 1H), 
7.48 (t, J = 7.6 Hz, 2H), 6.09 (dd, J = 17.3, 10.6 Hz, 1H), 5.96 (bs, 1H), 5.48 (d, J = 
17.3 Hz, 1H), 5.40 (d, J = 10.6 Hz, 1H), 5.20 (d, J = 4.2 Hz, 1H), 4.53 (d, J = 8.6 Hz, 
1H), 4.18 (d, J = 8.6 Hz, 1H), 2.13 (m, 1H), 1.00 (d, J = 7.4 Hz, 3H), 1.00 (d, J = 7.4 
Hz, 3H); 13C NMR (101 MHz, CDCl3) d 166.1, 158.7, 136.2, 133.5, 129.7, 129.2, 128.6, 
116.6, 79.5, 72.3, 65.0, 29.3, 20.8, 17.5; IR (film): 3334, 2968, 2933, 1759, 1735 cm-1; 
HRMS (ESI+) calculated for C16H20NO4 [M+H]+ = 290.1387, found = 290.1386. 
(RS)-1-[(SR)-2-Oxo-4-vinyloxazolidin-4-yl]propyl benzoate (6b), 0.303 g (81%) 
from 0.293 g (1.37 mmol) of allene 1 as a colorless oil; Rf (hexanes/EtOAc 7:3) = 0.20; 
1H NMR (400 MHz, CDCl3) d 8.06 (t, J = 7.7 Hz, 2H), 7.58 (t, J = 7.7 Hz, 1H), 7.47 
(bs, 1H), 7.45 (t, J = 7.7 Hz, 2H), 6.03 (dd, J = 17.3, 10.7 Hz, 1H), 5.46 (d, J = 17.3 Hz, 
1H), 5.33 (d, J = 10.7 Hz, 1H), 5.28 (dd, J = 8.0, 2.0 Hz, 1H), 4.46 (d, J = 8.8 Hz, 1H), 
4.16 (d, J = 8.8 Hz, 1H), 1.81-1.64 (m, 2H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (101 
MHz, CDCl3) d 166.1, 159.6, 135.6, 133.3, 129.7, 129.2, 128.5, 116.9, 77.8, 72.4, 64.8, 
22.5, 10.1; IR (film): 3253, 2924, 2854, 1756, 1719, 1268, 1106 cm-1; HRMS (ESI+) 
calculated for C15H18NO4 [M+H]+ = 276.1230, found = 276.1232. 
(RS)-1-[(SR)-2-Oxo-4-vinyloxazolidin-4-yl]tridecyl benzoate (6c), 0.461 g (69%) 
from 0.348 g (1.62 mmol) of allene 1 as a colorless oil; Rf (hexanes/EtOAc 3:2) = 0.74; 
1H NMR (400 MHz, CDCl3) d 8.03-7.97 (m, 2H), 7.62-7.54 (m, 1H), 7.49-7.41 (m, 2H), 
6.00 (dd, J = 17.2, 10.7 Hz, 1H), 5.83 (bs, 1H), 5.42 (d, J = 17.2 Hz, 1H), 5.35 (d, J = 
10.7 Hz, 1H), 5.28 (dd, J = 8.9, 4.3 Hz, 1H), 4.45 (d, J = 8.7 Hz, 1H), 4.15 (d, J = 8.7 
Hz, 1H), 1.70-1.58 (m, 2H), 1.37-1.16 (m, 20H), 0.86 (t, J = 6.9 Hz, 3H); 13C NMR 
(101 MHz, CDCl3) d 166.3, 158.7, 136.2, 133.6, 129.9, 129.4, 128.7, 117.2, 76.2, 72.0, 
64.8, 35.7, 32.1, 29.8, 29.7, 29.6, 29.5, 29.5, 29.4, 25.8, 25.6, 22.8, 14.3; IR (ATR): 
3205, 2922, 2852, 1755, 1718, 1264, 1095, 709 cm-1; HRMS (ESI+) calculated for 
C25H38NO4 [M+H]+ = 416.2795, found = 416.2789. 
(RS)-[(SR)-2-Oxo-4-vinyloxazolidin-4-yl](phenyl)methyl benzoate (6d), 0.295 g 
(82%) from 0.240 g (1.11 mmol) of allene 1 as a colorless solid; mp = 72-74 °C; Rf 
(hexanes/EtOAc 7:3) = 0.18; 1H NMR (400 MHz, CDCl3) d 8.08 (d, J = 8.0 Hz, 2H), 
7.56-7.34 (m, 9H), 6.07 (dd, J = 18.0, 9.9 Hz, 1H), 6.06 (s, 1H), 5.38 (d, J = 18.0 Hz, 
1H), 5.35 (d, J = 9.9 Hz, 1H), 4.57 (d, J = 8.8 Hz, 1H), 4.17 (d, J = 8.8 Hz, 1H); 13C 
NMR (101 MHz, CDCl3) d 165.1, 159.3, 135.9, 134.5, 133.4, 129.7, 129.1, 129.0, 
128.4, 127.7, 117.1, 78.2, 71.8, 65.0; IR (KBr): 3462, 3215, 1753, 1712, 1269 cm-1; 
HRMS (ESI+) calculated for C19H18NO4 [M+H]+ = 324.1230, found = 324.1230. 
(RS)-1-[(SR)-2-Oxo-4-vinyloxazolidin-4-yl]allyl benzoate (6e), 0.282 g (84%) from 
0.263 g (1.22 mmol) of allene 1 as a yellow oil; Rf (hexanes/EtOAc 7:3) = 0.21; 1H 
NMR (400 MHz, CDCl3) d 8.04 (t, J = 7.8 Hz, 2H), 7.59 (t, J = 7.8 Hz, 1H), 7.49 (t, J = 
7.8 Hz, 2H), 6.41 (bs, 1H), 6.03 (dd, J = 17.3, 10.7 Hz, 1H), 5.87 (ddd, J = 17.3, 10.7, 
7.0 Hz, 1H), 5.57 (d, J = 7.0 Hz, 1H), 5.56 (d, J = 0.8 Hz, 1H), 5.54 (d, J = 17.3 Hz, 
1H), 5.46 (d, J = 17.3 Hz, 1H), 5.46 (d, J = 10.7 Hz, 1H), 4.50 (d, J = 8.8 Hz, 1H), 4.17 
(d, J = 8.8 Hz, 1H); 13C NMR (101 MHz, CDCl3) d 165.1, 159.4, 135.5, 133.4, 130.1, 
129.7, 129.2, 128.5, 122.0, 117.4, 77.4, 71.8, 64.1; IR (film): 3250, 1756, 1721, 1266, 
1070 cm-1; HRMS (ESI+) calculated for C14H16NO2 [M+H]+ = 230.1176, found = 
230.1176.  
(RS,E)-1-[(SR)-2-Oxo-4-vinyloxazolidin-4-yl]dodec-2-en-1-yl benzoate (6f), 0.331 g 
(74%) from 0.243 g (1.13 mmol) of allene 1 as a colorless oil; Rf (hexanes/EtOAc 4:1) = 
0.22; 1H NMR (400 MHz, CDCl3) d 8.04-7.98 (m, 2H), 7.59-7.53 (m, 1H), 7.46-7.41 
(m, 2H), 6.30 (bs, 1H), 6.05-5.96 (m, 2H), 5.54-5.41 (m, 3H), 5.35 (d, J = 10.7 Hz, 1H), 
4.46 (d, J = 8.7 Hz, 1H), 4.14 (d, J = 8.7 Hz, 1H), 2.05 (dt, J = 7.8, 4.0 Hz, =2H), 1.40-
1.31 (m, 2H), 1.30-1.19 (m, 12H), 0.86 (t, J = 6.9 Hz, 3H); 13C NMR (101 MHz, CDCl3) 
d 165.4, 159.1, 140.7, 136.2, 133.5, 129.8, 129.7, 128.7, 121.8, 117.3, 77.8, 72.2, 64.3, 
32.6, 32.0, 29.6, 29.5, 29.4, 29.3, 28.8, 22.8, 14.2; IR (ATR): 3240, 2923, 1755, 1707, 
1263, 709 cm-1; HRMS (ESI+) calculated for C24H37N2O4 [M+NH4]+ = 417.2748, found 
= 417.2747. 
(RS)-1-[(SR)-2-Oxo-4-vinyloxazolidin-4-yl]oct-2-yn-1-yl benzoate (6g). 0.340 g 
(90%) from 0.237 g (1.10 mmol) of allene 1 as a colorless solid; mp = 122-124 °C; Rf 
(hexanes/EtOAc 4:1) = 0.22; 1H NMR (400 MHz, CDCl3) d 8.02 (m, 2H), 7.59 (m, 1H), 
7.45 (m, 2H), 6.10 (dd, J = 17.2, 10.7 Hz, 1H), 5.79 (bs, 1H), 5.65 (t, J = 2.0 Hz, 1H), 
5.50 (d, J = 17.2 Hz, 1H), 5.39 (d, J = 10.7 Hz, 1H), 4.70 (d, J = 8.8 Hz, 1H), 4.20 (d, J 
= 8.8 Hz, 1H), 2.21 (dt, J = 7.1, 2.0 Hz, 2H), 1.53-1.48 (m, 2H), 1.35-1.27 (m, 4H), 0.88 
(t, J = 7.0 Hz, 3H); 13C NMR (101 MHz, CDCl3) d 165.2, 147.3, 135.2, 133.6, 130.9, 
129.0, 128.5, 117.6, 89.7, 73.1, 72.0, 67.8, 64.4, 31.0, 27.8, 22.0, 18.6, 13.9; IR (KBr): 
3243, 2932, 2860, 1760, 1684 cm-1; HRMS (ESI+) calculated for C20H24NO4 [M+H]+ = 
342.1700, found = 342.1696. 
(S)-[(2R,5R,6R)-5,6-Dimethoxy-5,6-dimethyl-1,4-dioxan-2-yl][(S)-2-oxo-4-
vinyloxazolidin-4-yl]methyl benzoate (6h), 0.448 g (85%) from 0.269 g (1.25 mmol) 
of allene 1 as a colorless solid; mp = 69-71 °C; Rf (hexanes/EtOAc 7:3) = 0.16; [a]D25 ̶ 
81.9 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) d 7.98 (d, J = 7.9 Hz, 2H), 7.63 (d, J 
= 7.9 Hz, 1H), 7.48 (d, J = 7.9 Hz, 2H), 6.27 (dd, J = 17.2, 10.6 Hz, 1H), 5.85 (bs, 1H), 
5.59 (d, J = 17.2 Hz, 1H), 5.48 (d, J = 10.6 Hz, 1H), 5.33 (d, J = 8.7 Hz, 1H), 4.36 (d, J 
= 8.7 Hz, 1H), 4.31-4.23 (m, 1H), 4.05 (d, J = 8.7 Hz, 1H), 3.73 (t, J = 11.4 Hz, 1H), 
3.40 (dd, J = 11.4, 3.4 Hz, 1H), 3.27 (s, 3H), 3.25 (s, 3H), 1.32 (s, 3H), 1.25 (s, 3H); 13C 
NMR (101 MHz, CDCl3) d 165.1, 158.1, 135.6, 134.1, 129.8, 128.3, 127.6, 117.2, 99.6, 
98.1, 74.7, 73.7, 67.5, 63.3, 60.8, 49.2, 48.2, 17.5, 17.5; IR (KBr): 3342, 2991, 2949, 
1763, 1726 cm-1; HRMS (ESI+) calculated for C21H28NO8 [M+H]+ = 422.1809, found = 
422.1806. 
(1S,2R)-2-[(tert-Butyldiphenylsilyl)oxy]-1-[(S)-2-oxo-4-vinyloxazolidin-4-yl]propyl 
benzoate (6i), 0.673 g (84%) from 0.324 g (1.51 mmol) of allene 1 as a colorless oil; Rf 
(hexanes/EtOAc 4:1) = 0.24; [a]D25 +31.7 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
d 8.00 (m, 2H), 7.60-7.71 (m, 5H), 7.35-7.50 (m, 8H), 6.05 (dd, J = 17.3, 10.7 Hz, 1H), 
5.59 (bs, 1H), 5.44 (d, J = 17.3 Hz, 1H), 5.39 (d, J = 10.7 Hz, 1H), 5.30 (m, 1H), 4.41 
(d, J = 8.7 Hz, 1H), 4.15 (m, 1H), 4.07 (d, J = 8.7 Hz, 1H), 1.06 (s, 9H), 1.03 (d, J = 6.3 
Hz, 3H); 13C NMR (101 MHz, CDCl3) d 158.8, 135.9, 135.7, 135.6, 133.5, 132.7, 130.1, 
129.9, 127.9, 127.7, 115.8, 78.7, 73.6, 70.7, 63.6, 27.0, 19.1, 18.9; IR (film): 3250, 
3070, 2931, 2858, 1759, 1728 cm-1; HRMS (ESI+) calculated for C31H36NO5Si [M+H]+ 
= 530.2356, found = 530.2357. 
(S)-4-[(1S,2R)-1,2-Dihydroxypropyl]-4-vinyloxazolidin-2-one (7). A solution of 
K2CO3 (0.154 g, 1.10 mmol) in MeOH (10 mL) was added to a solution of carbamate 6i 
(0.389 g, 0.735 mmol) in MeOH (10 mL) at rt under N2 atmosphere. The mixture was 
stirred for 2 h. Water (10 mL) was added and the mixture was extracted with CH2Cl2 (3 
x 20 mL). The combined organic phase was dried over MgSO4 and the solvent was 
evaporated under vacuum. The crude residue was purified by column chromatography 
(hexanes/EtOAc 3:2) to afford a mixture of debenzoylated products (0.224 g, 86% 
yield). A solution of TBAF·3H2O (0.201 g, 0.62 mmol) and acetic acid (35 µL, 0.6 
mmol) in anhydrous THF (10 mL) was added via cannula to the mixture of 
debenzoylated products (0.175 g, 0.41 mmol) in anhydrous THF (10 mL). The solution 
was stirred at rt for 5 h. Phosphate buffer solution (pH = 7, 10 mL) was added and the 
aqueous layer was extracted with EtOAc (5 x 20 mL). The combined organic layer was 
dried over anhydrous MgSO4, and the solvent was evaporated under vacuum. The crude 
residue was purified by column chromatography (CH2Cl2/MeOH, 95:5) to afford 
carbamate 7 (0.060 g, 0.32 mmol) in 78% yield: colorless oil; Rf (EtOAc) = 0.35; [a]D25 
+31.5 (c = 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) d 6.10 (dd, J = 17.4, 10.7 Hz, 1H), 
5.40 (d, J = 17.4, 1H), 5.35 (d, J = 10.7 Hz, 1H), 4.49 (d, J = 8.8 Hz, 1H), 4.14 (d, J = 
8.8 Hz, 1H), 3.69-3.62 (m, 4H), 3.37 (d, J = 8.5 Hz, 1H), 1.25 (d, J = 6.2 Hz, 3H); 13C 
NMR (101 MHz, CDCl3) d 135.2, 116.1, 78.4, 74.1, 69.2, 64.5, 20.9; IR (film): 3379, 
2922, 1737, 1396, 933, 721 cm-1; HRMS (ESI+) calculated for C8H14NO4 [M+H]+ = 
188.0916, found = 188.0917. 
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